Physician profile
Jodi A Loyd
NPI 1184854382
$5,357.21
in general payments reported to CMS, 2019-2025
21 companies · $18.00 in 2025
The $18.00 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,216 · 2022: $2,623 · 2023: $459 · 2024: $41.74 · 2025: $18.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $500 · Education: $18.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $500.32 |
| Education | $18.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,194.80 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $532.16 | 2021-2023 | Brilinta, Farxiga |
| Janssen Pharmaceuticals, INC | $473.18 | 2021-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $238.28 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $199.48 | 2021-2023 | Jardiance |
| Amgen INC. | $196.30 | 2021-2023 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $189.04 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $179.13 | 2021-2023 | Verquvo |
| Cvrx, INC. | $171.39 | 2022 | |
| Pfizer INC. | $167.74 | 2021-2023 | |
| Boston Scientific Corporation | $159.34 | 2021-2023 | Watchman Access System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $144.34 | 2021-2023 | Lifevest |
| Medtronic, INC. | $140.61 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $132.19 | 2021-2022 | |
| Esperion Therapeutics, INC. | $69.85 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $64.93 | 2021-2024 | |
| Philips North America LLC | $31.83 | 2022 | |
| Alnylam Pharmaceuticals INC. | $23.58 | 2022 | |
| Convatec INC. | $17.08 | 2022 | |
| Elutia, INC. | $17.06 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $14.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jodi Loyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.